Dicerna Pharmaceuticals Inc.

06/22/2021 | Press release | Distributed by Public on 06/22/2021 05:35

Dicerna Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of Belcesiran for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease